Skip to content
Clinical Trials – home

Emmaues

Verifiedinfo

Belgium Liersesteenweg 435, 2800 Mechelen, Belgium

  • 33 trials recruiting
  • Non-small cell lung cancer · Arteriosclerosis · Chronic obstructive pulmonary disease
  • Adults and children

About Specializations

Emmaues in Mechelen, Belgium specialises in clinical trials of conditions such as Non-small cell lung cancer, Arteriosclerosis, Chronic obstructive pulmonary disease, Asthma, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology and Hematologic Malignancies

At Emmaues, cancer research is a major focus, with studies spanning non-small cell lung cancer, small cell lung cancer, breast cancer, colorectal cancer, and several lymphomas and leukemias. The trials are designed to test new treatment options, compare them with current standards, and improve outcomes for patients with advanced or hard-to-treat disease.

  • Non-small cell lung cancer, small cell lung cancer, and lung cancer are central research areas
  • Breast cancer, colorectal cancer, and neuroendocrine tumours are also represented
  • Studies in CLL, SLL, DLBCL, and multiple myeloma explore better treatment effectiveness

Much of the work at this hospital-based research site is aimed at evaluating targeted therapies, immunotherapy combinations, and more effective approaches for patients whose cancers have progressed after earlier treatment.

Respiratory Medicine and Pulmonary Disease

Research in respiratory tract diseases is especially active, covering asthma, COPD, chronic cough, bronchiectasis, and pneumonia. These trials focus on improving symptom control, reducing flare-ups, and finding better long-term options for people living with chronic breathing disorders.

  • Asthma studies include uncontrolled and type 2 inflammatory disease
  • COPD trials aim to lower exacerbations and support better daily function
  • Chronic cough, bronchiectasis, and pneumonia research addresses persistent respiratory symptoms and infection-related illness

The respiratory portfolio at Emmaues also includes work on immune-based therapies, reflecting a broader effort to improve both treatment effectiveness and quality of life.

Cardiovascular, Metabolic, and Kidney-Related Research

Trials in cardiovascular diseases and nutritional and metabolic diseases examine conditions such as atherosclerotic cardiovascular disease, elevated lipoprotein(a), hypertriglyceridemia, obesity, and weight management. There is also research involving chronic kidney disease and systemic inflammation, with the goal of reducing major heart events and improving metabolic health.

  • Cardiovascular disease studies focus on preventing heart attack, stroke, and related complications
  • Lipoprotein(a) and triglyceride research explores new ways to lower lipid-related risk
  • Obesity and weight management trials assess treatments that support healthier body weight

These studies at the AZ Sint Maarten department in Mechelen aim to improve prevention and long-term control of cardiometabolic disease.

Immunology, Infectious Disease, and Vaccination Research

This site also contributes to research on virus diseases, bacterial infections, and immune system phenomena. Trials include studies of influenza, respiratory syncytial virus, human metapneumovirus, urinary tract infections, and COVID-19, along with vaccine studies in healthy adults and older populations.

  • Influenza and RSV vaccine studies evaluate protection and immune response
  • UTI research looks at prevention of E. coli-related infection
  • COVID-19 and other respiratory infection studies assess treatment support and disease control

The research activity here reflects a strong interest in preventing infection, strengthening immune protection, and improving care for common community and seasonal illnesses.

Neurology and Symptom Management

Clinical trials in nervous system diseases at Emmaues include migraine and chronic cough-related symptom burden, with a broader emphasis on easing persistent symptoms that affect daily life. These studies aim to improve control of recurring neurological and airway-related complaints.

  • Chronic migraine and episodic migraine are being studied to reduce attack frequency
  • Refractory and unexplained chronic cough research targets troublesome long-term symptoms
  • Trials focus on better symptom relief and improved patient well-being

By addressing conditions that can be disabling even when not life-threatening, this research supports more practical and patient-centered care.

Digestive, Liver, and Inflammation-Related Research

The site’s work in digestive system diseases includes studies of cirrhosis and other conditions linked to liver damage and fluid balance. Some trials also examine inflammation-related disease processes, reflecting interest in how chronic illness affects multiple organ systems.

  • Cirrhosis of the liver is a key area of investigation
  • Studies evaluate treatments intended to improve disease control and patient stability
  • Immune system and inflammation research connects with broader internal medicine care

These studies add to the broader clinical research profile at the hospital/clinic, where complex chronic diseases are being studied across several specialties.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Liersesteenweg 4352800 MechelenBelgium
Recruiting now
33 trials
Conditions studied
54
Partner status
Verified

More sites in MechelenBelgium

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

82 clinical trials

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:BelgiumBelgium
  • Participants:65+ years · Healthy volunteers
  • Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
  • Sponsor:GlaxoSmithKline Biologicals
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Siltuximab
  • Sponsor:Amgen Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:VMX-C001
  • Sponsor:VarmX B.V.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.